Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss URGN - UroGen Pharma Ltd.
12 K
LAST VALUE
57.48%
2 YEAR CAGR
15.05%
5 YEAR CAGR
1818.51%
10 YEAR CAGR